Figure 6.Risk score comparison in subsets of the clinical characteristics (gender, age at diagnosis, and AJCC pathological stage).
Figure 6 — A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy | Aging
